NYSE - Delayed Quote • USD
Cencora, Inc. (COR)
At close: April 22 at 4:00 PM EDT
Pre-Market: 4:55 AM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 15 | 15 | 18 | 17 |
| Avg. Estimate | 3.7 | 3.24 | 13.45 | 14.6 |
| Low Estimate | 3.23 | 3.11 | 13.33 | 12.95 |
| High Estimate | 3.87 | 3.39 | 13.54 | 15.26 |
| Year Ago EPS | 3.5 | 2.92 | 11.99 | 13.45 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 12 | 12 | 15 | 15 |
| Avg. Estimate | 70.65B | 73.67B | 291.98B | 310.6B |
| Low Estimate | 69.6B | 72.76B | 289.23B | 304.13B |
| High Estimate | 71.23B | 74.33B | 295.65B | 317.31B |
| Year Ago Sales | -- | -- | 262.17B | 291.98B |
| Sales Growth (year/est) | -- | -- | 11.40% | 6.40% |
Earnings History
| CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
|---|---|---|---|---|
| EPS Est. | 3.29 | 2.82 | 2.8 | 2.89 |
| EPS Actual | 3.5 | 2.92 | 2.86 | 3.28 |
| Difference | 0.21 | 0.1 | 0.06 | 0.39 |
| Surprise % | 6.40% | 3.50% | 2.10% | 13.50% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 3.7 | 3.24 | 13.45 | 14.6 |
| 7 Days Ago | 3.7 | 3.24 | 13.45 | 14.6 |
| 30 Days Ago | 3.7 | 3.24 | 13.45 | 14.59 |
| 60 Days Ago | 3.7 | 3.24 | 13.45 | 14.57 |
| 90 Days Ago | 3.69 | 3.17 | 12.91 | 14.04 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | 1 |
| Up Last 30 Days | 1 | 1 | 3 | 2 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | 1 | -- |
Growth Estimates
| CURRENCY IN USD | COR | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | 5.70% | -- | -- | 0.20% |
| Next Qtr. | 11.00% | -- | -- | 9.40% |
| Current Year | 12.20% | -- | -- | 4.40% |
| Next Year | 8.60% | -- | -- | 13.40% |
| Next 5 Years (per annum) | 10.01% | -- | -- | 11.07% |
| Past 5 Years (per annum) | 14.26% | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Initiated | Leerink Partners: Outperform | 2/26/2024 |
| Maintains | Mizuho: Neutral to Neutral | 2/5/2024 |
| Initiated | Barclays: Overweight | 1/3/2024 |
| Initiated | Wells Fargo: Equal-Weight | 12/14/2023 |
Related Tickers
MCK McKesson Corporation
527.32
+0.47%
CAH Cardinal Health, Inc.
102.83
-4.95%
HSIC Henry Schein, Inc.
72.04
+1.67%
PDCO Patterson Companies, Inc.
25.91
-0.42%
OMI Owens & Minor, Inc.
24.23
-2.26%
EDAP EDAP TMS S.A.
7.15
-1.52%
ZYXI Zynex, Inc.
11.14
-2.11%
PFRM3.SA Profarma Distribuidora de Produtos Farmacêuticos S.A.
5.92
+3.14%
MCK.F McKesson Corporation
493.80
-1.16%